Alligator Bioscience Ab【0RK9】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

23.00

買値

0.00

売値

0.00

出来高

5,000

0.00 日の範囲 0.00

23.00 52 週間の範囲 23.00

時価総額

15.133B

前日終値

23.00

始値

時刻

5000

0.28

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

6,962

発行済株式数

657,954,000

配当利回り

PER

-60.88

1 株当たり利益 (EPS)

-0.38

歳入

59.27M

純利益

-248.59M

セクター

Noncomml Resh Organizations

業界

Noncomml Resh Organizations

ウェブサイト

www.alligatorbioscience.se

本社

Lund, Swe

設立

Alligator Bioscience Ab is listed in the Noncomml Resh Organizations sector of the ロンドン証券取引所 with ticker 0RK9. The last closing price for Alligator Bioscience Ab was SEK23. Over the last year, Alligator Bioscience Ab shares have traded in a share price range of SEK 23.00 to SEK 23.00.

Alligator Bioscience Ab currently has 657,954,000 shares in issue. The market capitalisation of Alligator Bioscience Ab is SEK15.13 billion. Alligator Bioscience Ab has a price to earnings ratio (PE ratio) of -60.88.

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

期間 †	始値	高値	安値	平均出来高	VWAP
1	23	23	23	18006	23	DE
4	23	23	23	16254	23	DE
12	23	23	23	6962	23	DE
26	23	23	23	3740	23	DE
52	23	23	23	3056	23	DE
156	23	23	23	1799	23	DE
260	23	23	23	1903	23	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PPSProton Motor Power Systems Plc	0.55p (83.33%)	5.86M
CADCadogan Energy Solutions Plc	4.25p (77.08%)	14.62M
KZGKazera Global Plc	1.525p (35.56%)	89.49M
WEBWebis Holdings Plc	0.125p (19.05%)	4.67M
PETPetrel Resources Plc	1.35p (17.39%)	1.43M
MILAMila Resources Plc	0.35p (-30.00%)	33.37M
IPXImpax Asset Management Group Plc	250.00p (-23.66%)	3.14M
RNEPEcofin U.s. Renewables Infrastructure Trust Plc	26.20p (-19.88%)	21.5k
PMPPortmeirion Group Plc	174.00p (-15.12%)	58.93k
ROCKRockfire Resources Plc	0.165p (-13.16%)	190.11M
NTVONativo Resources Plc	0.0024p (0.00%)	967.12M
TRPTower Resources Plc	0.027p (1.89%)	481.24M
VRSVersarien Plc	0.034p (11.48%)	374.02M
ORCPOracle Power Plc	0.0315p (-11.27%)	305M
CPXCap-xx Limited	0.145p (0.00%)	260.82M